Skip to main content

Table 1 Demographic characteristics of cancer patients in Korea in 2006, NHIS-NSC

From: Impact of comorbidity assessment methods to predict non-cancer mortality risk in cancer patients: a retrospective observational study using the National Health Insurance Service claims-based data in Korea

  Total (n = 2979) Male (n = 1514) Female (n = 1465)
n % n % n %
Age, mean (SD), median 57.4 (15.4) 59.0 59.1 (15.0) 62.0 55.5 (15.6) 55.0
Survival time in years, mean (SD), median 7.1 (3.4) 9.2 6.6 (2.1) 9.0 7.8 (3.1) 9.3
Sex
 Male 1514 50.8     
 Female 1465 49.2     
Cause of Death
 Cancer death 686 23.0 434 28.7 252 17.2
 Other cancer death 135 4.5 86 5.7 49 3.3
 Non-cancer death 238 8.0 150 9.9 88 6.0
 Alive 1920 64.5 844 55.7 1076 73.4
Cancer type (ICD-10)
 Stomach (C16) 491 16.5 328 21.7 163 11.01
 Colon and rectum (C18-C20) 403 13.5 232 15.3 171 11.7
 Liver (C22) 258 8.7 183 12.1 75 5.1
 Gallbladder (C23-C24) 60 2.0 25 1.7 35 2.4
 Pancreas (C25) 58 1.9 29 1.9 29 2.0
 Lung (C33-C34) 232 7.8 157 10.4 75 5.1
 Bladder (C67) 71 2.4 61 4.0 10 .7
 Thyroid (C73) 295 9.9 54 3.6 241 16.5
 Non-Hodgkin lymphoma (C82-C85, C96) 57 1.9 31 2.0 26 1.8
 Genital organs a) 592 19.9 133 8.8 459 31.3
 Other Cancer b) 462 15.5 281 18.6 181 12.4
  1. SD Standard deviation, NHIS-NSC National Health Insurance Service-National Sample Cohort
  2. a) Cancer sites are masked and grouped: Breast (C50), Vulva (C51), Vagina (C52), Cervix uteri (C53), Corpus uteri (C54), Uterus unspecified (C55), Ovary (C56), other female genital organs (C57), Placenta (C58) in females and Penis (C60), Prostate (C61), Testis (C62), and other male genital organs (C63) in males
  3. b) “Other cancers” include Lip, oral cavity, and pharynx (C00-C14), Esophagus (C15), Larynx (C32), Kidney (C64), Brain and central nervous system (CNS) (C70-C72), Hodgkin lymphoma (C81), Multiple myeloma (C90), Leukemia (C91-C95), and Other malignant neoplasms (Remainder C00–C97)